Cite

    Waljee, A. et al. (2020). Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study. Lancet gastroenterology and hepatology. pp. 276-284. [Online].